Print this page


Fresenius Kabi Anti-Infectives ( is a part of the Fresenius Kabi group, specialized in cGMP manufacturing of the API beta-lactam antibiotics, both oral and sterile grades. With the latest state-of-the-art technologies, we supply pharmaceutical companies worldwide with a range of anti-infective products for human and veterinary use. Since the foundation in 1975, the group has continuously developed its presence in semi-synthetic penicillin and cephalosporin markets. Our portfolio is complemented with several new APIs every year as our strong commitment is to help our customers to launch first generics in their markets.

Having almost 40-years of experience in the field of beta-lactam APIs we offer to all our customers extensive technical, development and regulatory service supported by project management structure. Today we have two plants in Italy where we manufacture APIs and intermediates, one in Villadose (Rovigo), near Venice and another one in Taccona di Muggio, (Milan region). As our strong commitment is to support our current and future customers we continue to expand our production capacities. We operate in Europe, South America, North Africa, Asia (including Japan), Australia and USA based on long-term relationships with customers.